In two years the American Stock Exchange Biotech index has collapsed 60%.

FORBES: Biopipeline

Indeed, the American Stock Exchange Pharmaceutical Index is down more than 30% from its peak at the end of 2000, and off 23% since the beginning of 2002.

FORBES: Magazine Article

While the American Stock Exchange's pharmaceutical index has sunk some 5% in the past six months, its biotech index has risen by 10%.

FORBES: Big Pharma's Ails Could Spread To Biotech

The American Stock Exchange's 50-share Internet index lost more than 2.5% before recovering slightly.

BBC: News | The Economy | Bear market mood spreads